Suppr超能文献

一种用于大肠杆菌中CRISPR介导的基因组编辑和CRISPRi基因调控的质粒工具集。

A plasmid toolset for CRISPR-mediated genome editing and CRISPRi gene regulation in Escherichia coli.

作者信息

Jervis Adrian J, Hanko Erik K R, Dunstan Mark S, Robinson Christopher J, Takano Eriko, Scrutton Nigel S

机构信息

Manchester Centre for Fine and Speciality Chemicals (SYNBIOCHEM), Manchester Institute of Biotechnology, University of Manchester, Manchester, M1 7DN, UK.

出版信息

Microb Biotechnol. 2021 May;14(3):1120-1129. doi: 10.1111/1751-7915.13780. Epub 2021 Mar 12.

Abstract

CRISPR technologies have become standard laboratory tools for genetic manipulations across all kingdoms of life. Despite their origins in bacteria, the development of CRISPR tools for engineering bacteria has been slower than for eukaryotes; nevertheless, their function and application for genome engineering and gene regulation via CRISPR interference (CRISPRi) has been demonstrated in various bacteria, and adoption has become more widespread. Here, we provide simple plasmid-based systems for genome editing (gene knockouts/knock-ins, and genome integration of large DNA fragments) and CRISPRi in E. coli using a CRISPR-Cas12a system. The described genome engineering protocols allow markerless deletion or genome integration in just seven working days with high efficiency (> 80% and 50%, respectively), and the CRISPRi protocols allow robust transcriptional repression of target genes (> 90%) with a single cloning step. The presented minimized plasmids and their associated design and experimental protocols provide efficient and effective CRISPR-Cas12 genome editing, genome integration and CRISPRi implementation. These simple-to-use systems and protocols will allow the easy adoption of CRISPR technology by any laboratory.

摘要

CRISPR技术已成为所有生命王国中进行基因操作的标准实验室工具。尽管CRISPR起源于细菌,但用于工程改造细菌的CRISPR工具的开发比用于真核生物的要慢;然而,它们通过CRISPR干扰(CRISPRi)进行基因组工程和基因调控的功能及应用已在多种细菌中得到证实,并且应用越来越广泛。在这里,我们提供了基于简单质粒的系统,用于使用CRISPR-Cas12a系统在大肠杆菌中进行基因组编辑(基因敲除/敲入以及大DNA片段的基因组整合)和CRISPRi。所描述的基因组工程方案可在短短七个工作日内高效地进行无标记缺失或基因组整合(分别>80%和50%),并且CRISPRi方案通过单个克隆步骤即可对靶基因进行强大的转录抑制(>90%)。所展示的最小化质粒及其相关的设计和实验方案提供了高效且有效的CRISPR-Cas12基因组编辑、基因组整合和CRISPRi实施。这些易于使用的系统和方案将使任何实验室都能轻松采用CRISPR技术。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/188b/8085919/48f58bdc8fc1/MBT2-14-1120-g003.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验